Universal Ibogaine Inc. IBO.V
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · universalibogaine.com
Universal Ibogaine Inc. is a Canadian life sciences company that develops and operates addiction treatment clinics and conducts clinical research into ibogaine-based therapies. The company is focused on addressing the opioid crisis and is pioneering regulatory approval for ibogaine treatment in Canada, with studies targeting addiction to opioids, alcohol, and cocaine. Headquartered in Calgary, Alberta.
Key ratios
FreeCashFlowOnSale TTM -0.32
FreeCashFlowOnSale 2024 -0.39
FreeCashFlowOnSale 2023 -1.41
FreeCashFlowOnSale 2022 -4.14
NetIncomeMargin TTM -0.72
NetIncomeMargin 2024 -0.88
NetIncomeMargin 2023 -2.32
ReturnOnAssets TTM -0.09
ReturnOnAssets 2024 -0.11
ReturnOnAssets 2023 -0.22
ReturnOnAssets 2022 -0.58
ReturnOnEquity 2024 -1.5
ReturnOnEquity 2023 -0.84
ReturnOnEquity 2022 -3.05
TotalRevenueYoYGrowth TTM -0.12
TotalRevenueYoYGrowth 2024 1.26
TotalRevenueYoYGrowth 2023 -0.04